entimo moves up in environmental rating entimo’s 2025 Climate Change rating from CDP (formerly the Carbon Disclosure Project) has improved significantly compared to 2024, and now stands at a B level. This marks meaningful progress in our environmental transparency and climate action efforts. A rating at this level recognizes verified, evidence-based climate action and shows that entimo has moved from awareness into meaningful implementation. This is also the highest score a company can achieve without public CDP disclosure, and it highlights not only our progress, but the strength of...

Inside the 33rd BVMA Symposium: Reflections from entimo’s CEO Marc Jantke The 33rd BVMA Symposium in Munich brought together an extraordinary cross-section of Germany’s clinical research landscape including industry leaders, regulatory agencies, CROs, sponsors, NGOs, and government representatives. For entimo’s CEO, Marc Jantke, it was his first time stepping into what some attendees call a “class reunion.” As it turned out, the nickname was more accurate than he expected.   BVMA Symposium Recap Marc describes the opening get-together as “a fantastic opportunity to connect with...

entimo Presents at PHUSE US Connect 2025 Jörn Bilow (l) and Marc Jantke welcome visitors to the entimo booth at the 2025 PHUSE US Connect. In March, entimo representatives joined industry colleagues at PHUSE US Connect in Orlando, Florida to drive conversations around innovations in SCEs and clinical data standards. Three from entimo delivered presentations, while the company sponsored the conference’s poster session. entimo CEO Marc Jantke talked about the potential use of AI to overcome the validation burden for open-source packages. The talk discussed how LLMs can be used...

entimo at PHUSE EU Connect 2024 The entimo team at the 2024 PHUSE EU Connect in Strasbourg, France: Jens Wientges, Monika Böselt, Jörn Bilow and Sven Prasse (l to r) The 2024 PHUSE EU Connect saw record-breaking participation, boasting the largest in-person attendance at Connect to date! Jörn Bilow and Shivoy Pandita gave a talk in the software demonstrations stream about the integration of entimo’s next generation SCE entimICE FastTrack with Posit tools such as Posit Workbench and Posit Connect, utilizing the system's Open API for running R Shiny applications, while maintaining...

entimo climate targets accepted by validation organization The Science Based Targets initiative (SBTi), an international organization dedicated to fighting the climate crisis, has accepted the targets set by entimo for reducing our carbon emissions. This is the first step in having our efforts recognized internationally by a global group that monitors emission reduction goals in line with what the latest climate science says is needed to prevent the worst effects of climate change. The process will continue with commitments to these targets and evaluation of how well entimo meets...

Release of entimICE® FastTrack 3.1 strengthens integration Just weeks after the 3.0 release, entimo has updated its integrated CDR/SCE entimICE FastTrack to version 3.1. System users now can benefit from additional interfaces, including connections to Veeva Vault EDC, Posit Workbench and Lixoft Monolix/Simulx. The new interfaces facilitate data processing, standardization and transformation with these third-party tools, providing another level of R/Python Open Source tool integration. Management of study deliverables has been improved with capabilities to assign and track tasks and monitor...

entimo at the PHUSE Computational Science Symposium The entimo team at the 2024 PHUSE Computational Science Symposium in Silver Spring, Maryland: Shivoy Pandita (l) and Jörn Bilow (r) entimo participated in the PHUSE Computational Science Symposium (CSS), held June 3-5, 2024 in Silver Spring, Maryland, USA. entimo proudly supported the event and sponsored the poster session. PHUSE CSS is a unique opportunity for an open exchange between the biopharma industry and regulatory authorities, helping to shape the future of clinical data science, and to accelerate regulatory submissions...

entimo Enters Posit Reseller Agreement Entimo AG and Posit PBC officially entered a reseller agreement on March 28th, 2024. This enables entimo to provide entimICE FastTrack, the cloud-based Clinical Data Repository and Statistical Computing Environment, in combination with Posit Workbench, Posit Connect and Posit Package Manager as a bundled Software as a Service offer to pharmaceutical, biotech and CRO customers. Entimo AG is known for providing truly language-agnostic and regulatory compliant solutions for clinical data management and statistical analysis to the industry, scaling...

entimICE® FastTrack 3.0 release entimo has released version 3.0 of its integrated SCE/CDR solution. entimICE FastTrack in its latest version now provides automated program run sequences, durable object properties providing metadata information for up- and downstream processes or references to central libraries and standards, as well as integration with Pinnacle 21 Enterprise. Users benefit from comprehensive deliverable snapshots, improved security features, new system reports, and much more. With this latest version of FastTrack, clinical data science receives a significant boost towards...

entimo Presentations at PHUSE US Connect 2024 The entimo team at the 2024 PHUSE US Connect in Bethesda, Maryland: Ivo Marek, Jörn Bilow, Shivoy Pantida (l to r) At the 2024 PHUSE US Connect, entimo team members gave two presentations to interested attendees. Jörn Bilow and Shivoy Pandita gave a talk in the software demonstrations stream about automation within entimICE FastTrack utilizing the system's Open API from R programs, while maintaining full traceability and regulatory compliance. Ivo Marek presented with Boehringer Ingelheim on innovative randomization algorithms currently...

Making progress on sustainability goals entimo is making substantial progress on the road towards sustainability, to ultimately live up to our green company color. In scope of the efforts in 2023, entimo has disclosed the corporate sustainability benchmark reports to a scoring platform and rating agency. Overall results show significant improvements in environmental and supply chain sustainability, leading to a superior score compared to last year. entimo is extremely proud to be rated in the top percentiles of the industry and will continue this journey towards...

entimo Presents at PHUSE EU Connect 2023 The entimo team at PHUSE EU Connect 2023: Sven Prasse, Dmitry Zakharov, Marc Jantke, Jörn Bilow and Shivoy Pandita (l to r) At PHUSE EU Connect 2023, held in Birmingham in November, three teams from entimo gave presentations to the clinical data science conference. Marc Jantke, entimo CEO, and Javeed Paray (Abbott) gave a talk titled, “Application Development: Go-live for a new SCE is not the end of a journey but just another spot along the way.” Shivoy Pandita and Suchitra Ramaswamy (Zifo) discussed the benefits of integrated data...

2023 entimICE® User Group Meeting For the ninth time, entimo invited its entimICE customers to the annual User Group Meeting. The two-day agenda was filled with presentations, discussions, interactive workshops and an evening event. Two new clients, both users of the next generation data science platform entimICE FastTrack, participated for the first time along with customers who will continue to use entimICE DARE.

entimICE® FastTrack 2.1 release entimo has released version 2.1 of its integrated SCE/CDR solution. entimICE FastTrack in its latest version now provides new advanced visualization capabilities to review dependencies from data capture to submission. Users benefit from the capability to identify potentially outdated results and update them easily by relevant program reruns. On a higher level, submission readiness and data fitness are reported in comprehensive dashboards for both single studies as well as across multiple studies. Thus, clinical data science receives a...